| Delafloxacin: design, development and potential place in therapy FJ Candel, M Peñuelas Drug design, development and therapy, 881-891, 2017 | 70 | 2017 |
| Real time surveillance of COVID-19 space and time clusters during the summer 2020 in Spain N Rosillo, J Del-Águila-Mejía, A Rojas-Benedicto, M Guerrero-Vadillo, ... BMC Public Health 21 (1), 961, 2021 | 27 | 2021 |
| Compendio de microbiología JJ Picazo, JP Prieto, LA Cervera, RA Lobato, AA Vilela, EB Muñoz, ... Compendio de microbiología, 2016 | 21 | 2016 |
| Assessing the effect of non-pharmaceutical interventions on COVID-19 transmission in Spain, 30 August 2020 to 31 January 2021 D García-García, R Herranz-Hernández, A Rojas-Benedicto, ... Eurosurveillance 27 (19), 2100869, 2022 | 17 | 2022 |
| Fungal infections following treatment with monoclonal antibodies and other immunomodulatory therapies FJ Candel, M Peñuelas, C Tabares, C Garcia-Vidal, M Matesanz, ... Revista Iberoamericana de Micología 37 (1), 5-16, 2020 | 16 | 2020 |
| Lactancia materna. Volviendo a los cincuenta MRM Fernández, MJG Peñuelas, AMC Galiano, AVS Rosado, B Hindi, ... SEMERGEN-Medicina de Familia 30 (4), 159-163, 2004 | 12 | 2004 |
| Indicator opportunistic infections after biological treatment in rheumatoid arthritis, 10 years follow-up in a real-world setting L Leon, M Peñuelas, FJ Candel, D Freites, L Rodriguez-Rodriguez, ... Therapeutic Advances in Musculoskeletal Disease 11, 1759720X19878004, 2019 | 9 | 2019 |
| Dermatitis de contacto por tatuaje temporal con henna negra en tres niños de una misma familia ALM Rodríguez, MS Calderón, MJG Peñuelas, AS Sanz, RG Quiroga, ... SEMERGEN-Medicina de Familia 31 (5), 230-234, 2005 | 7 | 2005 |
| Botulism in Spain: Epidemiology and Outcomes of Antitoxin Treatment, 1997–2019 M Peñuelas, M Guerrero-Vadillo, S Valdezate, MJ Zamora, I Leon-Gomez, ... Toxins 15 (1), 2, 2022 | 6 | 2022 |
| Manejo de los síntomas en pacientes terminales en atención primaria (I) MJG Peñuelas, MLL Martínez, JP Alonso Semergen: revista española de medicina de familia, 312-321, 1999 | 6 | 1999 |
| Brotes de transmisión alimentaria. Red Nacional de Vigilancia Epidemiológica. 2012-2020 A Chong, M Peñuelas, M Guerrero, C Cabezas, O Díaz, C Martín, R Cano, ... Boletín epidemiológico semanal 29 (5), 53-63, 2021 | 4 | 2021 |
| Update in Infectious Diseases 2016 FJ Candel, AB García-García, M Peñuelas, A García-Alvarez, F Chiarella, ... Revista espanola de quimioterapia: publicacion oficial de la Sociedad …, 2016 | 4* | 2016 |
| Hepatitis A Outbreak Characteristics: A Comparison of Regions with Different Vaccination Strategies, Spain 2010–2018 A Domínguez, C Varela, N Soldevila, C Izquierdo, M Guerrero, ... Vaccines 9 (11), 1214, 2021 | 3 | 2021 |
| In vitro activity of imipenem/relebactam against Gram-negative clinical isolates in two Spanish tertiary hospitals M Peñuelas, C García-Salguero, M Iñigo, JM Viñuela-Prieto, FJ Candel, ... Revista Española de Quimioterapia 34 (6), 668, 2021 | 3 | 2021 |
| Estudio sobre la seguridad infantil en el automóvil. Situación actual y perspectivas AMC Galiano, MRM Fernández, MCP Bueno, MJG Peñuelas, ... SEMERGEN-Medicina de Familia 31 (4), 154-160, 2005 | 3 | 2005 |
| Epidemic diffusion network of Spain: A mobility model to characterize the transmission routes of disease J Del-Águila-Mejía, D García-García, A Rojas-Benedicto, N Rosillo, ... International Journal of Environmental Research and Public Health 20 (5), 4356, 2023 | 2 | 2023 |
| Botulism in Spain: Epidemiology and Outcomes of Antitoxin Treatment, 1997–2019. Toxins 2023, 15, 2 M Peñuelas, M Guerrero-Vadillo, S Valdezate, MJ Zamora, I Leon-Gomez, ... | 1 | 2022 |
| Impact of lockdown on COVID-19 transmissibility during the first pandemic wave in Spain P Fernández-Navarro, O Nuñez, D Pampaka, C Mazagatos, M Peñuelas, ... Available at SSRN 3811670, 2021 | 1 | 2021 |
| Vigilancia epidemiológica de Shigelosis en España, 2016-2021 M Guerrero-Vadillo, M Peñuelas, SH León, BS Rodriguez, A Díaz, ... Boletín epidemiológico semanal 29 (8), 90-98, 2021 | 1 | 2021 |
| AB0290 HERPES ZOSTER INFECTIONS IN RHEUMATOID ARTHRITIS PATIENTS EXPOSED TO BIOLOGICAL AGENTS AND JAK INHIBITORS. REAL-WORLD EVIDENCE. DF Nuñez, L Abasolo, M Peñuelas, FJ Candel, J Font, P Lois, CM Prada, ... Annals of the Rheumatic Diseases 79 (Suppl 1), 1444-1444, 2020 | 1 | 2020 |
